← All Companies
Caris Life Sciences, Inc.
CAI · Nasdaq · SIC 8071: Services-Medical Laboratories
Business Summary Part I Overview We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. We found...
Next Earnings Q2 FY2026 — expected 2026-08-11
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention CAI discussed_in_filing Artificial Intelligence topic_mention CAI discussed_in_filing Trusted Computing topic_mention CAI discussed_in_filing Blockchain & Crypto topic_mention CAI discussed_in_filing Regulation topic_mention CAI discussed_in_filing Healthcare & Bio topic_mention CAI discussed_in_filing Platform & Ecosystem topic_mention CAI discussed_in_filing Artificial Intelligence topic_mention CAI discussed_in_filing Trusted Computing topic_mention CAI discussed_in_filing Blockchain & Crypto topic_mention CAI discussed_in_filing Regulation topic_mention CAI discussed_in_filing Healthcare & Bio topic_mention CAI discussed_in_filing Platform & Ecosystem topic_mention CAI discussed_in_filing Artificial Intelligence topic_mention CAI discussed_in_filing Trusted Computing topic_mention CAI discussed_in_filing Blockchain & Crypto topic_mention CAI discussed_in_filing Regulation topic_mention CAI discussed_in_filing Healthcare & Bio topic_mention CAI discussed_in_filing Platform & Ecosystem topic_mention CAI discussed_in_filing Artificial Intelligence topic_mention CAI discussed_in_filing Trusted Computing
Annual Reports (10-K) Filed Period Accession Source Full Text 2026-03-03 2025-12-31 0002019410-26-000016 EDGAR 114K words
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2025-11-05 2025-09-30 0002019410-25-000028 EDGAR 93K words 2025-08-12 2025-06-30 0002019410-25-000012 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-04-02 0002019410-26-000019 EDGAR 1K words 2026-02-26 0002019410-26-000011 EDGAR — 2026-01-12 0002019410-26-000005 EDGAR — 2025-11-05 0002019410-25-000026 EDGAR — 2025-10-30 0002019410-25-000020 EDGAR — 2025-08-12 0002019410-25-000011 EDGAR — 2025-06-20 0001104659-25-061148 EDGAR —
13 total filings indexed. 3 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0002019410
Ticker CAI
Exchange Nasdaq
SIC 8071: Services-Medical Laboratories
Incorporated TX
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 4b8d44fb473ee1f08f0e4e2ada026660e2f0e5c54f8280ed875634c8e2e9de95
parent: 88781c2116e8e77fc509b400b40fdeb0ad6964b48ff38b04a11d94996fa8b77b
content hash: 89d394d14f29d5464e89a7242e994fc6695aecedb0885eb7ece4ffc7137937a0
signed: 2026-04-13T04:44:11.038Z
sources: 3 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf